I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 5 studies | 18% ± 3% | |
| B cell | 5 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 2% | |
| endothelial cell | 5 studies | 22% ± 5% | |
| epithelial cell | 5 studies | 40% ± 15% | |
| mucosal invariant T cell | 4 studies | 17% ± 1% | |
| astrocyte | 4 studies | 21% ± 6% | |
| ciliated cell | 4 studies | 30% ± 14% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 18% ± 1% | |
| classical monocyte | 3 studies | 22% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| non-classical monocyte | 3 studies | 24% ± 7% | |
| intestinal crypt stem cell | 3 studies | 20% ± 2% | |
| gamma-delta T cell | 3 studies | 23% ± 5% |
